Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Intelgenx Technologies Corp IGXT

IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ... see more

GREY:IGXT - Post Discussion

Intelgenx Technologies Corp > OPENING AT $1.15 TOMORROW
View:
Post by mram on Oct 01, 2018 4:22pm

OPENING AT $1.15 TOMORROW

Tilray Inc. TLRY


TLRY   ----- IS UNSTOPPABLE !!!!!!  WHILE IGXT BITES THE DUST !!!

Last Price
164.98
Day Change
21.3614.87%
 
Mon Oct 01, 2018
 
04:00 PM
 
USD
 
Delayed
Comment by biggerr on Oct 03, 2018 1:42pm
what a disaster, eh. When are they signing the final agreement with Johny Tilray, maybe that will help
Comment by virgo85 on Oct 15, 2018 6:50am
Shites....FCUK...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities